Inhibiting endothelial cell Mst1 attenuates acute lung injury in mice
JCI Insight · 2024
DOI: 10.1172/jci.insight.178208 ↗Kurz gefasst
Fachartikel in der Zeitschrift JCI Insight, 2024. Verfasst von Zhi-Fu Guo und 8 weiteren Autor:innen. Beteiligte Einrichtung: Center for Translational Medicine, Thomas Jefferson University, Philadelphia, Pennsylvania, USA. Hauptthemen laut MEDLINE: Acute Lung Injury, Endothelial Cells, Lipopolysaccharides, Lung. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NHLBI NIH HHS, NHLBI.
Abstract (Originalsprache)
Lung endothelium plays a pivotal role in the orchestration of inflammatory responses to acute pulmonary insults. Mammalian sterile 20-like kinase 1 (Mst1) is a serine/threonine kinase that has been shown to play an important role in the regulation of apoptosis, stress responses, and organ growth. This study investigated the role of Mst1 in lung endothelial activation and acute lung injury (ALI). We found that Mst1 was significantly activated in inflamed lung endothelial cells (ECs) and mouse lung tissues. Overexpression of Mst1 promoted nuclear factor κ-B (NF-κB) activation through promoting JNK and p38 activation in lung ECs. Inhibition of Mst1 by either its dominant negative form (DN-Mst1) or its pharmacological inhibitor markedly attenuated cytokine-induced expression of cytokines, chemokines, and adhesion molecules in lung ECs. Importantly, in a mouse model of lipopolysaccharide-induced (LPS-induced) ALI, both deletion of Mst1 in lung endothelium and treatment of WT mice with a pharmacological Mst1 inhibitor significantly protected mice from LPS-induced ALI. Together, our findings identified Mst1 kinase as a key regulator in controlling lung EC activation and suggest that therapeutic strategies aimed at inhibiting Mst1 activation might be effective in the prevention and treatment of inflammatory lung diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Center for Translational Medicine, Thomas Jefferson University, Philadelphia, Pennsylvania, USA.
- Department of Cardiology, Changhai Hospital, Naval Medical University, Shanghai.
Förderung
- NHLBI NIH HHS
- NHLBI
Zitieren
APA
Guo, Z. F., Tongmuang, N., Li, C., Zhang, C., Hu, L., Capreri, D., Zuo, M. X., Summer, R., & Sun, J. (2024). Inhibiting endothelial cell Mst1 attenuates acute lung injury in mice. JCI Insight. https://doi.org/10.1172/jci.insight.178208
Vancouver
Guo ZF, Tongmuang N, Li C, Zhang C, Hu L, Capreri D, et al. Inhibiting endothelial cell Mst1 attenuates acute lung injury in mice. JCI Insight. 2024. doi:10.1172/jci.insight.178208
BibTeX
@article{Guo2024,
author = {Guo, Zhi-Fu and Tongmuang, Nopprarat and Li, Chao and Zhang, Chen and Hu, Louis and Capreri, Daniel and Zuo, Mei-Xing and Summer, Ross and Sun, Jianxin},
title = {Inhibiting endothelial cell Mst1 attenuates acute lung injury in mice},
journal = {JCI Insight},
year = {2024},
doi = {10.1172/jci.insight.178208}
}
EUVIMED